Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2000 R21 PAR-99-102 GRIFFITH, JEFFREY K UNIVERSITY OF NEW MEXICO PROGNOSTIC VALUE OF TELOMERE DNA IN PROSTATE BIOPSY Complete
2002 R33 PAR-98-067 SHERRY, A. DEAN UNIVERSITY OF TEXAS DALLAS MRI AGENTS SENSITIVE TO BIOLOGICAL INDICATORS OF NEOPLAS Complete
2005 R33 RFA-CA-05-003 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO TYPING THE TRANSCRIPTOME IN CANCER USING SPLICING ARRAY Complete
2008 R21 RFA-CA-07-037 KNUDSEN, BEATRICE S FRED HUTCHINSON CANCER RESEARCH CENTER TISSUE LYSATES FOR STUDIES OF PROTEIN PHOSPHORYLATION Complete
2011 R21 RFA-CA-10-005 SHENDURE, JAY ASHOK UNIVERSITY OF WASHINGTON ULTRASENSITIVE IDENTIFICATION AND PRECISE QUANTITATION OF LOW FREQUENCY SOMATIC M Complete
2015 R33 RFA-CA-14-004 CARON, MARC G. DUKE UNIVERSITY A CANCER RAINBOW MOUSE FOR SIMULTANEOUS ASSESSMENT OF MULTIPLE ONCOGENES Complete
2018 R33 RFA-CA-17-013 INCE, TAN A. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers Complete
1999 R43 PAR-98-066 RICHTERICH, PETER CODONCODE CORPORATION SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION Complete
1999 R43 PAR-98-066 GOLDRICK, MARIANNA M AMBION, INC. DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA Complete
2002 R21 PAR-01-104 KNAPP, DANIEL R. MEDICAL UNIVERSITY OF SOUTH CAROLINA MICROFLUIDIC SYSTEM FOR CANCER PROTEOME ANALYSIS Complete
2005 R21 RFA-CA-05-002 WYMAN, ROBERT J YALE UNIVERSITY GENETIC METHODS FOR DETECTING GAP JUNCTION COMMUNICATION Complete
2007 R44 RFA-CA-07-008 DOLINGER, DAVID LEE IQUUM, INC. RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS Complete
2010 R42 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2014 R44 PAR-13-327 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
1999 R21 PAR-98-067 GARNER, HAROLD R UNIVERSITY OF TEXAS SW MED CTR/DALLAS SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES Complete
2001 R33 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2003 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. ARTIFICIAL ANTIBODY MIMETICS Complete
2007 R21 RFA-CA-07-002 SEGALL, JEFFREY E ALBERT EINSTEIN COLLEGE OF MEDICINE DEVELOPMENT OF AN IN VIVO METASTASIS SCREEN Complete
2009 R44 RFA-CA-07-041 LEE, BRIAN W IMMUNOCHEMISTRY TECHNOLOGIES, LLC NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO Complete
2013 R33 RFA-CA-13-002 HSIAO, SHIH-CHIA ADHEREN, INC. THE DEVELOPMENT OF A MICROSCOPY-BASED CELL-ARRAY TOXICITY ASSAY FOR QUANTIFYING C Complete
2000 R43 PAR-99-101 WOOD, KATHERINE A TREVIGEN, INC. HIGH THROUGHPUT DNA REPAIR CAPACITY ASSAY Complete
2002 R43 PAR-01-105 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS TECHNOLOGY FOR GENOME-WIDE CANCER METHYLATION PROFILING Complete
2006 R21 RFA-CA-06-004 COTE, RICHARD JAMES UNIVERSITY OF SOUTHERN CALIFORNIA INTEGRATED MICRODEVICE TO CAPTURE AND DETECT CIRCULATING TUMOR CELLS Complete
2009 R21 RFA-CA-08-006 CHAREST, JOSEPH LEO CHARLES STARK DRAPER LABORATORY MICROFLUIDIC 3D SCAFFOLD ASSAY FOR CANCER CELL MIGRATION AND INTRAVASATION Complete
2013 R21 RFA-CA-12-002 BAI, MINGFENG UNIVERSITY OF PITTSBURGH AT PITTSBURGH A NOVEL THERANOSTIC PLATFORM FOR TARGETED CANCER THERAPY AND TREATMENT MONITORING Complete
2016 R21 RFA-CA-15-002 SEGAL, DAVID J UNIVERSITY OF CALIFORNIA AT DAVIS CRISPR-BASED EPIGENETIC MODIFIERS Complete
2000 R21 PAR-99-102 OH, SEAJIN SRI INTERNATIONAL AFM BASED TECHNIQUE--ANALYZES EXPRESSION IN CANCER CELLS Complete
2002 R33 PAR-98-067 GIESE, ROGER WALLACE NORTHEASTERN UNIVERSITY CATION LABELING MASS SPECTROMETRY OF DNA ADDUCTS Complete
2005 R33 RFA-CA-05-003 SHIBATA, DARRYL K UNIVERSITY OF SOUTHERN CALIFORNIA HOW DO COLORECTAL CANCERS ARISE DESPITE SURVEILLANCE? Complete
2008 R33 RFA-CA-07-034 POOLE, LESLIE B. WAKE FOREST UNIVERSITY HEALTH SCIENCES PROTEOMIC PROFILING OF CANCER-RELATED REDOX SIGNALING PATHWAYS Complete
2011 R21 RFA-CA-10-005 HUANG, SONGPING D KENT STATE UNIVERSITY AT KENT PRUSSIAN BLUE NANOPARTICLES AS CELLULAR T1 MRI CONTRAST AGENTS Complete
2015 R33 RFA-CA-14-004 ZHU, HENG JOHNS HOPKINS UNIVERSITY DEVELOPMENT OF A VIRION DISPLAY (VIRD) ARRAY TO PROFILE HUMAN GPCR INTERACTIONS Complete
2020 R21 RFA-CA-19-019 TEWARI, MUNEESH UNIVERSITY OF MICHIGAN AT ANN ARBOR Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers Active
2019 R33 RFA-CA-18-003 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES Optimization and validation of integrated microscale technologies for low-cost; automated production of PET molecular imaging tracers for cancer research Active
2020 R33 RFA-CA-19-020 WANG, SIYUAN YALE UNIVERSITY Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer Active
2019 R21 RFA-CA-18-004 SINGAMANENI, SRIKANTH WASHINGTON UNIVERSITY METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION Active
2018 R21 RFA-CA-17-010 ABBOTT, KAREN L UNIV OF ARKANSAS FOR MED SCIS Novel platform linking cancer-specific glycosylation with cell signaling outcomes Active
2020 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active
2019 R21 RFA-CA-18-004 ANDRES-MARTIN, LAURA NEW YORK STEM CELL FOUNDATION Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections Active
2018 R21 RFA-CA-17-010 BRENT, ROGER FRED HUTCHINSON CANCER RESEARCH CENTER Precision controllers of mammalian gene expression Active
2020 R33 RFA-CA-19-020 WEI, CHIA-LIN JACKSON LABORATORY Advancing Ultra Long-read Sequencing And Chromatin Interaction Analyses For Chromosomal And Extrachromosomal Structural Variation Characterization In Cancer Active
2019 R33 RFA-CA-18-005 LEI, YUGUO UNIVERSITY OF NEBRASKA LINCOLN A Single Conical Tube Device for Precision CAR-T Cells Manufacturing Active
2020 R44 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Active
2020 R21 RFA-CA-19-019 HUR, SOOJUNG CLAIRE JOHNS HOPKINS UNIVERSITY Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy Active
2020 R33 RFA-CA-19-020 HALL, ADAM ROGER WAKE FOREST UNIVERSITY HEALTH SCIENCES Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores Active
2020 R21 RFA-CA-19-019 REVZIN, ALEXANDER MAYO CLINIC ROCHESTER A microfluidic cell culture platform for personalizing pancreatic cancer therapies Active
2019 R21 RFA-CA-18-002 IM, HYUNGSOON MASSACHUSETTS GENERAL HOSPITAL Nano-plasmonic technology for high-throughput single exosome analyses Active
2018 R21 RFA-CA-17-010 FU, XIAO-AN UNIVERSITY OF LOUISVILLE A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath Active
2020 R33 RFA-CA-19-020 WANG, SHAOPENG ARIZONA STATE UNIVERSITY-TEMPE CAMPUS A Virion-Display Oscillator Array and Detection Platform for Quantification of Transmembrane Protein Binding Kinetics Active
2020 R21 RFA-CA-19-019 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics Active

Pages